Author:
Polan Rosa M.,Ali-Fehmi Rouba,Grace Anne K.,Mattei Larissa H.,Tanner Edward J.,Morris Robert T.
Reference20 articles.
1. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations;Rebbeck;N. Engl. J. Med.,2002
2. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation;Kauff;N. Engl. J. Med.,2002
3. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020;Daly;J. Natl. Compr. Cancer Netw.,2020
4. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology;Armstrong;J. Natl. Compr. Cancer Netw.,2021
5. Society of gynecologic oncologists clinical practice committee statement on prophylactic salpingo-oophorectomy;Gynecol. Oncol.,2005